| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Zeskind Benjamin J. serves as a President and CEO at IMRX. Across recent SEC filings that breaks down to 8 buys and 0 sells. Those positions are worth an estimated $10.6M at current prices.
Historically, Zeskind Benjamin J.'s trades have earned a middling insider score of 55/100 across 7 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -4.8%.
The biggest single holding is IMRX (~$10.6M) as President and CEO. Net of sales, the recent Form 4 record there shows accumulation of 60,581 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | IMRX Immuneering Corporation | President and CEO | Buy | 2,400 | $4.56 | $10,948.08 | +0.1% | -2.2% | - | |
| Jul 2, 2025 | IMRX Immuneering Corp | President and CEO | Buy | 10,000 | $3.49 | $34,879.33 | +0.4% | +95.0% | +44.6% | |
| Jun 18, 2025 | IMRX Immuneering Corp | President and CEO | Buy | 21,000 | $2.39 | $50,143.80 | +0.9% | +200.0% | - | |
| Mar 19, 2024 | IMRX Immuneering Corp | President and CEO | Buy | 20,000 | $2.77 | $55,326.00 | +0.9% | -40.3% | -34.6% | |
| Mar 23, 2022 | IMRX Immuneering Corp | President and CEO | Buy | 3,000 | $8.02 | $24,060.00 | +0.1% | -39.4% | +35.9% | |
| Sep 13, 2021 | IMRX Immuneering Corp | President and CEO | Buy | 2,083 | $22.87 | $47,631.96 | - | -10.6% | -48.7% | |
| Aug 3, 2021 | IMRX Immuneering Corp | President and CEO | Buy | 2,098 | $15.00 | $31,470.00 | - | +40.0% | -64.3% |